Deskripsi
Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.
Figure 2
ChartSource Paper
Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.Cite This Figure
![Figure 2: Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.]() > Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." *Nutrients*, 2018. PMID: [29701662](https://pubmed.ncbi.nlm.nih.gov/29701662/)
<figure> <img src="" alt="Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period." /> <figcaption>Figure 2. Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.<br> Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29701662/">29701662</a></figcaption> </figure>